Summit Therapeutics SMMT Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's convertible preferred stock authorized shares?
- Summit Therapeutics (SMMT) reported convertible preferred stock authorized shares of 20M in Q1 2026.
- How has Summit Therapeutics's convertible preferred stock authorized shares changed year-over-year?
- Summit Therapeutics's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 20M to 20M.
- What is the long-term trend for Summit Therapeutics's convertible preferred stock authorized shares?
- Over 4 years (2021 to 2025), Summit Therapeutics's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 20M to 20M.